Platinum (IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug delivery

被引:86
作者
Yang, Jun
Liu, Wenwen
Sui, Meihua [1 ]
Tang, Jianbin
Shen, Youqing
机构
[1] Zhejiang Univ, Ctr Bionanoengn, Hangzhou 310027, Peoples R China
基金
美国国家科学基金会; 中国博士后科学基金;
关键词
Platinum (IV)-conjugate; Platinum (IV) prodrug; Drug delivery; Reduction-responsive; ANTICANCER ACTIVITY; MOLECULAR-WEIGHT; RATIONAL DESIGN; IN-VITRO; CISPLATIN; COMPLEXES; NANOPARTICLES; PRODRUG; MICELLES; SERIES;
D O I
10.1016/j.biomaterials.2011.08.022
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Platinum (IV)-coordinate polymers were synthesized by condensation polymerization using diamminedichlorodihydroxyplatinum (DHP) or its dicarboxyl derivative diamminedichlorodisuccinatoplatinum (DSP) as comonomers. Cyclic voltammogram study showed that Pt (IV) in the polymers was much easier reduced to Pt (II), particularly at the acidic pH, than that in the monomer DSP. Thus, these polymers were intracellular reduction-responsive backbone-type polymer conjugates that could be degraded and release Pt (II). These conjugates not only had high and fixed platinum contents (27.7% for P(DSP-EDA) and 29.6% for P(DSP-PA), respectively), but also showed increased cytotoxicity compared with corresponding Pt (IV) monomer DSP toward various tumor cell lines. In vivo, the conjugate showed a longer blood circulation time and better tumor accumulation. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:9136 / 9143
页数:8
相关论文
共 51 条
  • [1] Enhancement of In Vivo Anticancer Effects of Cisplatin by Incorporation Inside Single-Wall Carbon Nanohorns
    Ajima, Kumiko
    Murakami, Tatsuya
    Mizoguchi, Yoshikazu
    Tsuchida, Kunihiro
    Ichihashi, Toshinari
    Iijima, Sumio
    Yudasaka, Masako
    [J]. ACS NANO, 2008, 2 (10) : 2057 - 2064
  • [2] Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: Influence of the ligands on drug efficacies and uptake
    Ang, WH
    Pilet, S
    Scopelliti, R
    Bussy, F
    Juillerat-Jeanneret, L
    Dyson, PJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (25) : 8060 - 8069
  • [3] Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance
    Ang, WH
    Khalaila, I
    Allardyce, CS
    Juillerat-Jeanneret, L
    Dyson, PJ
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (05) : 1382 - 1383
  • [4] Enzymatic reduction of disulfide bonds in lysosomes: Characterization of a Gamma-interferon-inducible lysosomal thiol reductase (GILT)
    Arunachalam, B
    Phan, UT
    Geuze, HJ
    Cresswell, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) : 745 - 750
  • [5] Polymer-Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery
    Aryal, Santosh
    Hu, Che-Ming Jack
    Zhang, Liangfang
    [J]. ACS NANO, 2010, 4 (01) : 251 - 258
  • [6] Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes
    Barnes, KR
    Kutikov, A
    Lippard, SJ
    [J]. CHEMISTRY & BIOLOGY, 2004, 11 (04): : 557 - 564
  • [7] SYNTHESIS, CHARACTERIZATION, AND PROPERTIES OF A GROUP OF PLATINUM(IV) COMPLEXES
    BRANDON, RJ
    DABROWIAK, JC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (07) : 861 - 865
  • [8] Nanoparticles in cancer therapy and diagnosis
    Brigger, I
    Dubernet, C
    Couvreur, P
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) : 631 - 651
  • [9] New trends for metal complexes with anticancer activity
    Bruijnincx, Pieter C. A.
    Sadler, Peter J.
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (02) : 197 - 206
  • [10] Reduction and anticancer activity of platinum(IV) complexes
    Choi, S
    Filotto, C
    Bisanzo, M
    Delaney, S
    Lagasee, D
    Whitworth, JL
    Jusko, A
    Li, CR
    Wood, NA
    Willingham, J
    Schwenker, A
    Spaulding, K
    [J]. INORGANIC CHEMISTRY, 1998, 37 (10) : 2500 - 2504